| Application no. and date | 03716244.3 (espacenet) (Federated) (European Patent Register), 20030227 | | Patent/reg. no. and date | DK/EP 1478394, 20080730 | | Publication date | 20041124 | | Priority no. and date | US 360257 P, 20020227 | | EP pub. no. and date |
EP 1478394 20041124 | | Effective date | | | Applicant/owner | IMMUNEX CORPORATION, One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Applicant ref. no. | P80828720DK00E | | Inventor | GOMBOTZ, Wayne, R., 15545 61st Avenue NE
Kenmore, WA 98028, US,
REMMELE, Richard, L., Jr., 3120 153rd Place S.W.
Lynnwood, WA 98037, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/38 (2006.01) , A61K 39/395 (2006.01) | | Title | Stabiliseret TNFR-Fc formulation med arginin | | Int. application no. | US2003006222 | | Int. publication no. | WO2003072060 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
